Development of the anti-tumor DDS based on novel tumor-homing peptides
基于新型肿瘤归巢肽的抗肿瘤DDS的开发
基本信息
- 批准号:21200078
- 负责人:
- 金额:$ 19.8万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)
- 财政年份:2009
- 资助国家:日本
- 起止时间:2009 至 2011
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We developed novel tumor linegae-homing CPPs that are highly permeable to cancer cells according to their tumor linages. Random peptide library constructed by mRNA display technology was employed for isolating the CPPs encoded by novel aminoacid sequences which differ from conventional CPPs such as TAT,pAnt. Screening of over 40 CPPs of these,10 of them showed unique response that were efficiently incorporated to tumor cells following their tumor origins. These tumor linage-homing CPPs were efficiently incorporated to target cells in vivo and in vitro and are useful in peptide-based non-invasive medical technologies such as anti-cancer therapeutics and imaging.
我们开发了新的肿瘤谱系归巢CPP,其根据其肿瘤谱系对癌细胞具有高度渗透性。利用mRNA展示技术构建的随机肽库,筛选出与达特、pAnt等传统CPP不同的新氨基酸序列编码的CPP。筛选其中超过40种CPP,其中10种显示出独特的反应,这些反应在肿瘤起源后有效地掺入肿瘤细胞。这些肿瘤谱系归巢CPP在体内和体外有效地掺入靶细胞,并且可用于基于肽的非侵入性医疗技术,如抗癌治疗和成像。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tumour lineage-homing cell-penetrating peptides for peptide-based anti-cancer molecular delivery systems. (※ correspondence ; Kondo E and Matsushita M)
用于基于肽的抗癌分子递送系统的肿瘤谱系归巢细胞穿透肽(※对应;Kondo E 和 Matsushita M)。
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:16.6
- 作者:Kondo E;Saito K;Tashiro Y;Kamide K;Uno S;Furuya T;Mashita M;Nakajima K;Tsumuraya T;Kobayashi N;Nishibori M;Tanimoto M;Matsushita M
- 通讯作者:Matsushita M
ヒト各種悪性腫瘍細胞におけるCXADR 分子の発現の特徴とその生物学的役割についての解析
CXADR分子在人多种恶性肿瘤细胞中的表达特征及其生物学作用分析
- DOI:
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:松井誠;中西速夫;近藤英作
- 通讯作者:近藤英作
Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential
- DOI:10.1007/s10120-012-0149-2
- 发表时间:2013-01-01
- 期刊:
- 影响因子:7.4
- 作者:Murakami, Hiroki;Nakanishi, Hayao;Kodera, Yasuhiro
- 通讯作者:Kodera, Yasuhiro
Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signaling pathway
通过 Akt/GSK-3β/snail 信号通路获得头颈鳞状细胞癌细胞系吉非替尼耐药细胞的 EMT 表型
- DOI:
- 发表时间:2012
- 期刊:
- 影响因子:0
- 作者:Oshiumi;H.;M.Matsumoto;T.Seya;朽津和幸;Iwamuro M
- 通讯作者:Iwamuro M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KONDO Eisaku其他文献
KONDO Eisaku的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KONDO Eisaku', 18)}}的其他基金
Development of the novel peptide restoring the tumor suppressor function for peptide-based antitumor therapeutics
开发恢复肿瘤抑制功能的新型肽,用于基于肽的抗肿瘤疗法
- 批准号:
25670263 - 财政年份:2013
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of the novel peptide-based therapeutics for the molecular targeting agent-resistant lung cancers.
开发针对分子靶向剂耐药性肺癌的新型肽疗法。
- 批准号:
23590442 - 财政年份:2011
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Comparative analysis of micro RNA expressions on between reactive lymphoid follicles and follicular lymphomas focusing to post-translational process.
反应性淋巴滤泡和滤泡性淋巴瘤之间微小RNA表达的比较分析,重点关注翻译后过程。
- 批准号:
20590366 - 财政年份:2008
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular analysis of Cyclin D1 in the development of mantle cell lymphoma
Cyclin D1 在套细胞淋巴瘤发生过程中的分子分析
- 批准号:
14570143 - 财政年份:2002
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of a novel mechanism of programmed cell death regulated by calcineurin.
分析钙调神经磷酸酶调节的程序性细胞死亡的新机制。
- 批准号:
10670207 - 财政年份:1998
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
細胞透過人工タンパク質による低分子抗がん剤の細胞内ドラッグデリバリー
使用细胞穿透人工蛋白进行小分子抗癌药物的细胞内药物递送
- 批准号:
24K08605 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ナノリポソームを用いたドラッグデリバリーによる自己炎症性疾患の治療戦略
纳米脂质体药物递送治疗自身炎症性疾病的策略
- 批准号:
24K11618 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
自浄機能と生理活性物質徐放ドラッグデリバリー機能をもつ多機能軟質リライン材の開発
开发具有自清洁功能和缓释生理活性物质的药物递送功能的多功能软衬材料
- 批准号:
23K27784 - 财政年份:2024
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
細菌およびマトリックス標的型バイオフィルム制御技術の確立と歯科用レジンへの応用
细菌和基质靶向生物膜控制技术的建立及其在牙科树脂中的应用
- 批准号:
23K09215 - 财政年份:2023
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of multifunctional soft denture liners with self-cleaning function and drug delivery function for sustained release of physiologically active substances
开发具有自清洁功能和缓释生理活性物质的药物输送功能的多功能软义齿衬垫
- 批准号:
23H03094 - 财政年份:2023
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of treatment to lymph node metastasis by Epitranscriptome regulation in Esophageal squamous cell carcinoma
表观转录组调控食管鳞癌淋巴结转移治疗进展
- 批准号:
23K15512 - 财政年份:2023
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
腫瘍特異的集積性を示すペプチド-DDSによる前立腺癌治療への応用
显示肿瘤特异性积累的肽-DDS 在前列腺癌治疗中的应用
- 批准号:
23K15776 - 财政年份:2023
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Verification of a new direct inner ear drug delivery by ultrafine perfusion needle
超细灌注针直接内耳给药的验证
- 批准号:
23K08905 - 财政年份:2023
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Inner ear pharmacokinetics and development of drug delivery systems targeting the inner ear barrier mechanism
内耳药代动力学和针对内耳屏障机制的药物递送系统的开发
- 批准号:
23K08952 - 财政年份:2023
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of a microplasma device for active transport of macromolecular drugs to in vivo tissue
创建用于将大分子药物主动转运至体内组织的微等离子体装置
- 批准号:
23K17473 - 财政年份:2023
- 资助金额:
$ 19.8万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)